| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.097 | 0.002 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.091 | 0.002 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.002 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.002 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.003 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.003 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.003 |